Concepedia

Matthew P. Davidsohn

MP

5

Publications

198

Citations

5

H-Index

2022

Active since

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Eli and Edythe Broad Foundation

Harvard University

Broad Institute

Matthew P. Davidsohn is an author at Brigham and Women's Hospital specializing in cancer therapeutics, cancer research, and prognostic biomarkers.

ORCID

Top concepts

Publications per year

2022–2024

5

Publications

5

Liquid biopsy epigenomic profiling for cancer subtyping

Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn et al. · Nature Medicine · 2023 · 97 citations · Full text

The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response

Jacob E. Berchuck, Elio Adib, Sarah Abou Alaiwi et al. · Cancer Research · 2022 · 38 citations · Full text

Detecting Small Cell Transformation in Patients with Advanced <i>EGFR</i> Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling

Talal El Zarif, Catherine B. Meador, Xintao Qiu et al. · Clinical Cancer Research · 2024 · 25 citations · Full text

Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma

Talal El Zarif, Karl Semaan, Marc Eid et al. · Cell Reports · 2024 · 22 citations · Full text

Outcomes in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV) after switch maintenance avelumab (MAv) in the UNITE study.

Amanda Nizam, Tanya Jindal, Cindy Jiang et al. · Journal of Clinical Oncology · 2024 · 16 citations

, , +20

Rows per page

1–5 of 5